



@article {3264,
	title = {The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium},
	journal = {Biomaterials},
	volume = {35},
	year = {2014},
	note = {Export Date: 21 November 2014},
	month = {2014},
	pages = {9199 - 9207},
	abstract = {Glucagon like peptide-1 (GLP-1) is an incretin hormone that is in the pipeline for type 2 diabetes mellitus (T2DM) therapy. However, oral administration of GLP-1 is hindered by the harsh conditions of the gastrointestinal tract and poor bioavailability. In this study, three nanosystems composed by three different biomaterials (poly(lactide-co-glycolide) polymer (PLGA), Witepsol E85 lipid (solid lipid nanoparticles, SLN) and porous silicon (PSi) were developed and loaded with GLP-1 to study their permeability invitro. All the nanoparticles presented a size of approximately 200nm. The nanoparticles{\textquoteright} interaction with the mucus and the intestinal cells were enhanced after coating with chitosan (CS). PSi nanosystems presented the best association efficiency (AE) and loading degree (LD), even though a high AE was also observed for PLGA nanoparticles and SLN. Among all the nanosystems, PLGA and PSi were the only nanoparticles able to sustain the release of GLP-1 in biological fluids when coated with CS. This characteristic was also maintained when the nanosystems were in contact with the intestinal Caco-2 and HT29-MTX cell monolayers. The CS-coated PSi nanoparticles showed the highest GLP-1 permeation across the intestinal invitro models. In conclusion, PLGA+CS and PSi+CS are promising nanocarriers for the oral delivery of GLP-1. {\textcopyright} 2014 Elsevier Ltd.},
	keywords = {chitosan, Diabetes, Glucagon like peptide-1, nanoparticles, Oral delivery systems, Triple co-culture},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84906788144\&partnerID=40\&md5=38c557a51eb271561ef59bfe12421842},
	author = {Ara{\'u}jo, F. and Shrestha, N. and Shahbazi, M.-A. and Fonte, P. and M{\"a}kil{\"a}, E.M. and Salonen, J.J. and Hirvonen, J.T. and Granja, P.L. and Santos, H.A. and Sarmento, B.}
}
